AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Deferasirox in South Africa

12 products registered with SAHPRA 6 active

Brand / ProductReg. No.HolderStatusExpires
SIROXTRIN 50056/27/1224Trinity Pharma (Pty) Ltdactive18 Mar 2030
SIROXTRIN 50056/27//1224Trinity Pharma (Pty) Ltdactive18 Mar 2030
SIROXTRIN 12556/27/1222Trinity Pharma (Pty) Ltdactive18 Mar 2030
SIROXTRIN 25056/27/1223Trinity Pharma (Pty) Ltdactive18 Mar 2030
DEFERASIROX 90 mg CIPLA53/27/0579.576Cipla Medpro (Pty) Ltdsuspended7 May 2026
NUJADE 180 mg53/27/0577Cipla Medpro (Pty) Ltdsuspended7 May 2026
DEFERASIROX 180 mg CIPLA53/27/0580.577Cipla Medpro (Pty) Ltdsuspended7 May 2026
DEFERASIROX 360 mg CIPLA53/27/0581.578Cipla Medpro (Pty) Ltdsuspended7 May 2026
NUJADE 360 mg53/27/0578Cipla Medpro (Pty) Ltdsuspended7 May 2026
NUJADE 90 mg53/27/0576Cipla Medpro (Pty) Ltdsuspended7 May 2026
EXJADE 500 mgA40/27/0268Novartis South Africa (Pty) Ltdactive1 Jan 1900
EXJADE 250 mgA40/27/0267Novartis South Africa (Pty) Ltdactive1 Jan 1900

DeferasiroxSAHPRA Registration Details

SAHPRA (South Africa) has 12 registered products containing Deferasirox, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Deferasirox registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.